ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,958Medicare Part D Prescriptions Filled, Including Refills

Rank: 310 out of 2604

$402K Total Retail Price of All Prescriptions

Rank: 377 out of 2604

401 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 401 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 401 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 5,698 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 300 234 1 4
OMEPRAZOLE 267 230 2 5
SIMVASTATIN 224 200 3 2
LISINOPRIL 191 137 4 3
FUROSEMIDE 165 152 5 8
METFORMIN HCL 162 129 6 7
POTASSIUM CHLORIDE 159 149 7 16
HYDROCHLOROTHIAZIDE 152 122 8 10
HYDROCODONE-ACETAMINOPHEN 139 102 S3 9 1
LOVASTATIN 125 99 10 24
METOPROLOL TARTRATE 123 123 11 9
AMLODIPINE BESYLATE 122 122 12 6
PRAVASTATIN SODIUM 114 73 13 14
ATENOLOL 114 104 13 11
METOPROLOL SUCCINATE 107 85 15 17
LOSARTAN POTASSIUM 105 100 16 20
FENTANYL 88 76 S2 17 48
GABAPENTIN 86 70 18 12
WARFARIN SODIUM 77 67 19 13
PANTOPRAZOLE SODIUM 76 64 20 64
ALLOPURINOL 76 54 20 35
FLUOXETINE HCL 73 61 22 49
CLONIDINE HCL 70 58 23 56
CARVEDILOL 69 63 24 26
ENALAPRIL MALEATE 69 58 24 50
RANITIDINE HCL 67 56 26 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 64 27 22
SERTRALINE HCL 64 48 28 23
AZITHROMYCIN 62 48 29 33
ATORVASTATIN CALCIUM 61 56 30 19
ALENDRONATE SODIUM 59 46 31 29
RISPERIDONE 52 34 32 65
TAMSULOSIN HCL 52 51 32 30
ISOSORBIDE MONONITRATE ER 52 52 32 38
ZOLPIDEM TARTRATE 51 44 35 21
CEPHALEXIN 51 42 35 74
FENOFIBRATE 50 43 37 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.